Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Alexandra Stowell et al.|Nature Cancer|2021Cited by 279
3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIABrian Liddicoat, Mark A. Dawson, Wendy Jia et al.|Experimental Hematology|2022Cited by 0